| GO:0003777 | microtubule motor activity | 12.99% (23/177) | 6.38 | 0.0 | 0.0 |
| GO:0007018 | microtubule-based movement | 12.99% (23/177) | 6.38 | 0.0 | 0.0 |
| GO:0006928 | movement of cell or subcellular component | 12.99% (23/177) | 6.38 | 0.0 | 0.0 |
| GO:0008017 | microtubule binding | 12.99% (23/177) | 6.17 | 0.0 | 0.0 |
| GO:0007017 | microtubule-based process | 12.99% (23/177) | 6.13 | 0.0 | 0.0 |
| GO:0003774 | motor activity | 12.99% (23/177) | 6.04 | 0.0 | 0.0 |
| GO:0015631 | tubulin binding | 12.99% (23/177) | 6.02 | 0.0 | 0.0 |
| GO:0008092 | cytoskeletal protein binding | 12.99% (23/177) | 5.38 | 0.0 | 0.0 |
| GO:0005524 | ATP binding | 27.12% (48/177) | 2.86 | 0.0 | 0.0 |
| GO:0008144 | drug binding | 27.12% (48/177) | 2.79 | 0.0 | 0.0 |
| GO:0032559 | adenyl ribonucleotide binding | 27.12% (48/177) | 2.77 | 0.0 | 0.0 |
| GO:0030554 | adenyl nucleotide binding | 27.12% (48/177) | 2.76 | 0.0 | 0.0 |
| GO:0006259 | DNA metabolic process | 11.3% (20/177) | 5.2 | 0.0 | 0.0 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 27.12% (48/177) | 2.68 | 0.0 | 0.0 |
| GO:0000166 | nucleotide binding | 28.81% (51/177) | 2.55 | 0.0 | 0.0 |
| GO:1901265 | nucleoside phosphate binding | 28.81% (51/177) | 2.55 | 0.0 | 0.0 |
| GO:0036094 | small molecule binding | 28.81% (51/177) | 2.49 | 0.0 | 0.0 |
| GO:0032555 | purine ribonucleotide binding | 27.12% (48/177) | 2.6 | 0.0 | 0.0 |
| GO:0017076 | purine nucleotide binding | 27.12% (48/177) | 2.59 | 0.0 | 0.0 |
| GO:0032553 | ribonucleotide binding | 27.12% (48/177) | 2.59 | 0.0 | 0.0 |
| GO:0097367 | carbohydrate derivative binding | 27.12% (48/177) | 2.58 | 0.0 | 0.0 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 15.82% (28/177) | 3.85 | 0.0 | 0.0 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 15.82% (28/177) | 3.83 | 0.0 | 0.0 |
| GO:0017111 | nucleoside-triphosphatase activity | 14.69% (26/177) | 3.86 | 0.0 | 0.0 |
| GO:0043168 | anion binding | 27.12% (48/177) | 2.42 | 0.0 | 0.0 |
| GO:0016462 | pyrophosphatase activity | 14.69% (26/177) | 3.77 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 32.77% (58/177) | 1.88 | 0.0 | 0.0 |
| GO:0043167 | ion binding | 29.38% (52/177) | 1.92 | 0.0 | 0.0 |
| GO:0097159 | organic cyclic compound binding | 32.2% (57/177) | 1.68 | 0.0 | 0.0 |
| GO:1901363 | heterocyclic compound binding | 32.2% (57/177) | 1.68 | 0.0 | 0.0 |
| GO:0090304 | nucleic acid metabolic process | 11.3% (20/177) | 3.3 | 0.0 | 0.0 |
| GO:0005488 | binding | 38.98% (69/177) | 1.25 | 0.0 | 0.0 |
| GO:0006139 | nucleobase-containing compound metabolic process | 11.3% (20/177) | 2.89 | 0.0 | 0.0 |
| GO:0016787 | hydrolase activity | 17.51% (31/177) | 2.11 | 0.0 | 0.0 |
| GO:0046483 | heterocycle metabolic process | 11.3% (20/177) | 2.7 | 0.0 | 0.0 |
| GO:0006725 | cellular aromatic compound metabolic process | 11.3% (20/177) | 2.69 | 0.0 | 0.0 |
| GO:0005515 | protein binding | 18.64% (33/177) | 1.88 | 0.0 | 0.0 |
| GO:1901360 | organic cyclic compound metabolic process | 11.3% (20/177) | 2.65 | 0.0 | 0.0 |
| GO:0051276 | chromosome organization | 3.39% (6/177) | 6.14 | 0.0 | 0.0 |
| GO:0006270 | DNA replication initiation | 2.82% (5/177) | 6.74 | 0.0 | 0.0 |
| GO:0006260 | DNA replication | 3.39% (6/177) | 5.55 | 0.0 | 0.0 |
| GO:0044260 | cellular macromolecule metabolic process | 16.95% (30/177) | 1.7 | 0.0 | 0.0 |
| GO:0034641 | cellular nitrogen compound metabolic process | 11.3% (20/177) | 2.17 | 0.0 | 0.0 |
| GO:0071103 | DNA conformation change | 2.26% (4/177) | 6.55 | 0.0 | 0.0 |
| GO:0140097 | catalytic activity, acting on DNA | 3.39% (6/177) | 4.73 | 0.0 | 1e-06 |
| GO:0008150 | biological_process | 35.03% (62/177) | 0.93 | 0.0 | 1e-06 |
| GO:0006996 | organelle organization | 3.39% (6/177) | 4.68 | 0.0 | 1e-06 |
| GO:0003677 | DNA binding | 10.17% (18/177) | 2.12 | 0.0 | 1e-06 |
| GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity | 1.69% (3/177) | 7.14 | 1e-06 | 4e-06 |
| GO:0061505 | DNA topoisomerase II activity | 1.69% (3/177) | 7.14 | 1e-06 | 4e-06 |
| GO:0043170 | macromolecule metabolic process | 16.95% (30/177) | 1.39 | 1e-06 | 6e-06 |
| GO:0008094 | DNA-dependent ATPase activity | 1.69% (3/177) | 6.88 | 2e-06 | 7e-06 |
| GO:0003682 | chromatin binding | 2.26% (4/177) | 5.42 | 2e-06 | 1e-05 |
| GO:0003824 | catalytic activity | 28.25% (50/177) | 0.94 | 3e-06 | 1.2e-05 |
| GO:0003916 | DNA topoisomerase activity | 1.69% (3/177) | 6.29 | 6e-06 | 2.8e-05 |
| GO:0006265 | DNA topological change | 1.69% (3/177) | 6.29 | 6e-06 | 2.8e-05 |
| GO:0061731 | ribonucleoside-diphosphate reductase activity | 1.13% (2/177) | 7.88 | 1.8e-05 | 7.7e-05 |
| GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 1.13% (2/177) | 7.88 | 1.8e-05 | 7.7e-05 |
| GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 1.13% (2/177) | 7.88 | 1.8e-05 | 7.7e-05 |
| GO:0006807 | nitrogen compound metabolic process | 16.38% (29/177) | 1.21 | 1.9e-05 | 8.2e-05 |
| GO:0044237 | cellular metabolic process | 16.95% (30/177) | 1.16 | 2.6e-05 | 0.000107 |
| GO:0006269 | DNA replication, synthesis of RNA primer | 1.13% (2/177) | 7.29 | 5.4e-05 | 0.000219 |
| GO:0016043 | cellular component organization | 3.95% (7/177) | 2.81 | 7e-05 | 0.000279 |
| GO:0003676 | nucleic acid binding | 11.3% (20/177) | 1.37 | 0.000102 | 0.000403 |
| GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 1.13% (2/177) | 6.88 | 0.000108 | 0.000417 |
| GO:0044238 | primary metabolic process | 17.51% (31/177) | 1.02 | 0.000123 | 0.000469 |
| GO:0005634 | nucleus | 3.95% (7/177) | 2.66 | 0.000137 | 0.000516 |
| GO:0071840 | cellular component organization or biogenesis | 3.95% (7/177) | 2.64 | 0.000147 | 0.000545 |
| GO:0071704 | organic substance metabolic process | 17.51% (31/177) | 0.96 | 0.000257 | 0.000939 |
| GO:0003674 | molecular_function | 40.68% (72/177) | 0.52 | 0.000264 | 0.000949 |
| GO:0043227 | membrane-bounded organelle | 3.95% (7/177) | 2.47 | 0.000301 | 0.001055 |
| GO:0043231 | intracellular membrane-bounded organelle | 3.95% (7/177) | 2.47 | 0.000301 | 0.001055 |
| GO:0043226 | organelle | 5.65% (10/177) | 1.91 | 0.000374 | 0.001275 |
| GO:0043229 | intracellular organelle | 5.65% (10/177) | 1.91 | 0.000374 | 0.001275 |
| GO:0009059 | macromolecule biosynthetic process | 5.08% (9/177) | 2.02 | 0.000419 | 0.001407 |
| GO:0003887 | DNA-directed DNA polymerase activity | 1.13% (2/177) | 5.18 | 0.001363 | 0.00452 |
| GO:0034061 | DNA polymerase activity | 1.13% (2/177) | 5.07 | 0.001586 | 0.00519 |
| GO:0008081 | phosphoric diester hydrolase activity | 1.13% (2/177) | 4.71 | 0.002636 | 0.008518 |
| GO:0042623 | ATPase activity, coupled | 1.69% (3/177) | 3.37 | 0.003103 | 0.009899 |
| GO:0006281 | DNA repair | 1.69% (3/177) | 3.33 | 0.003368 | 0.010611 |
| GO:0007076 | mitotic chromosome condensation | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:1905462 | regulation of DNA duplex unwinding | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:1905775 | negative regulation of DNA helicase activity | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:1905774 | regulation of DNA helicase activity | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:1905463 | negative regulation of DNA duplex unwinding | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0051097 | negative regulation of helicase activity | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0051095 | regulation of helicase activity | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0042555 | MCM complex | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0003896 | DNA primase activity | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0006323 | DNA packaging | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0000796 | condensin complex | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0030261 | chromosome condensation | 0.56% (1/177) | 7.88 | 0.004257 | 0.011293 |
| GO:0033646 | host intracellular part | 2.26% (4/177) | 2.57 | 0.004772 | 0.011789 |
| GO:0044217 | other organism part | 2.26% (4/177) | 2.57 | 0.004772 | 0.011789 |
| GO:0042025 | host cell nucleus | 2.26% (4/177) | 2.57 | 0.004772 | 0.011789 |
| GO:0033648 | host intracellular membrane-bounded organelle | 2.26% (4/177) | 2.57 | 0.004772 | 0.011789 |
| GO:0033647 | host intracellular organelle | 2.26% (4/177) | 2.57 | 0.004772 | 0.011789 |
| GO:0033643 | host cell part | 2.26% (4/177) | 2.57 | 0.004772 | 0.011789 |
| GO:0044464 | cell part | 7.34% (13/177) | 1.2 | 0.004631 | 0.012157 |
| GO:0034645 | cellular macromolecule biosynthetic process | 3.95% (7/177) | 1.76 | 0.005001 | 0.012235 |
| GO:0006974 | cellular response to DNA damage stimulus | 1.69% (3/177) | 3.23 | 0.004091 | 0.012422 |
| GO:0051716 | cellular response to stimulus | 1.69% (3/177) | 3.23 | 0.004091 | 0.012422 |
| GO:0033554 | cellular response to stress | 1.69% (3/177) | 3.23 | 0.004091 | 0.012422 |
| GO:0000776 | kinetochore | 0.56% (1/177) | 6.88 | 0.008497 | 0.019643 |
| GO:2001251 | negative regulation of chromosome organization | 0.56% (1/177) | 6.88 | 0.008497 | 0.019643 |
| GO:0031262 | Ndc80 complex | 0.56% (1/177) | 6.88 | 0.008497 | 0.019643 |
| GO:0006471 | protein ADP-ribosylation | 0.56% (1/177) | 6.88 | 0.008497 | 0.019643 |
| GO:0043044 | ATP-dependent chromatin remodeling | 0.56% (1/177) | 6.88 | 0.008497 | 0.019643 |
| GO:0031491 | nucleosome binding | 0.56% (1/177) | 6.88 | 0.008497 | 0.019643 |
| GO:0044424 | intracellular part | 6.78% (12/177) | 1.15 | 0.008639 | 0.019791 |
| GO:0016779 | nucleotidyltransferase activity | 1.69% (3/177) | 2.82 | 0.009069 | 0.020588 |
| GO:0008152 | metabolic process | 18.08% (32/177) | 0.6 | 0.010675 | 0.02402 |
| GO:0016886 | ligase activity, forming phosphoric ester bonds | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0003910 | DNA ligase (ATP) activity | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0006338 | chromatin remodeling | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0003909 | DNA ligase activity | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0051346 | negative regulation of hydrolase activity | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0051129 | negative regulation of cellular component organization | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0044092 | negative regulation of molecular function | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0010639 | negative regulation of organelle organization | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0043086 | negative regulation of catalytic activity | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0060249 | anatomical structure homeostasis | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0032200 | telomere organization | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0000723 | telomere maintenance | 0.56% (1/177) | 6.29 | 0.012718 | 0.025846 |
| GO:0044249 | cellular biosynthetic process | 5.08% (9/177) | 1.26 | 0.013884 | 0.027991 |
| GO:1901576 | organic substance biosynthetic process | 5.08% (9/177) | 1.18 | 0.019117 | 0.038233 |
| GO:1903047 | mitotic cell cycle process | 0.56% (1/177) | 5.55 | 0.021107 | 0.040602 |
| GO:0003950 | NAD+ ADP-ribosyltransferase activity | 0.56% (1/177) | 5.55 | 0.021107 | 0.040602 |
| GO:0031461 | cullin-RING ubiquitin ligase complex | 0.56% (1/177) | 5.55 | 0.021107 | 0.040602 |
| GO:0005680 | anaphase-promoting complex | 0.56% (1/177) | 5.55 | 0.021107 | 0.040602 |
| GO:0000152 | nuclear ubiquitin ligase complex | 0.56% (1/177) | 5.55 | 0.021107 | 0.040602 |
| GO:0016887 | ATPase activity | 1.69% (3/177) | 2.29 | 0.023879 | 0.045587 |
| GO:0033044 | regulation of chromosome organization | 0.56% (1/177) | 5.29 | 0.025275 | 0.047889 |